-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUPHORIA THERAPEUTICS INC - PAUSES R&D EXPENDITURES FOR BNC210 IN PTSD & IS EVALUATING ALL POSSIBILITIES AS PART OF THE CO'S STRATEGIC REVIEW

路透·12/04/2025 13:00:50

登录查看新闻详情